Methicillin-resistant Staphylococcus aureus; MSSA: Methicillin-susceptible Staphylococcus aureus. Staphylococcus aureus is a leading cause of nosocomial and community acquired infections.
MRSA - or methicillin resistant staphylococcus aureus - has already become resistant to most common antibiotics, making it difficult to treat with drugs. Once it gets into the body, through wounds ...
Without treatment, the infection can enter ... which is the incubation period for the infection. Methicillin-resistant Staphylococcus aureus (MRSA) is a type of staph bacteria highly resistant ...
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...
Antibiotic treatment during an influenza infection actually impaired the body’s efforts to clear bacteria rather than helping the body heal.
The microbe poses a significant threat to public health, made worse by the spread of methicillin-resistant Staphylococcus aureus bacteria (MRSA) in recent years. According to The Lancet ...
In April 2024, the U.S. Food and Drug Administration (FDA) approved Zevtera for three specific treatment indications, and it is the only FDA-approved methicillin-resistant Staphylococcus aureus ...
P-128 is under clinical development by GangaGen Biotechnologies and currently in Phase II for Staphylococcus aureus Infections.
Pune: Doctors have reported a steady increase in infections resistant to antibiotics among children in the city, indicating that humans without the us.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback